Product Pipeline:

BigDNA’s main purpose is to develop human vaccines, using our patented vaccine delivery platform. While we are also interested in the development of veterinary vaccines, this will be through collaboration or out-licensing.

This is reflected in our core product development portfolio, with our first three development projects tailored to producing vaccines against the human pathogens, Hepatitis B, Influenza and Chlamydia. Use the links on the left to find out more information about our three primary target diseases.